Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Operating Expenses | 15,109 | 12,728 | 6,918 | 7,219 | 16,216 |
| Operating Income | -15,109 | -12,728 | -6,918 | -7,219 | -16,216 |
| Interest Expense | 0 | 0 | 1,337 | 1 | 0 |
| Other Income | 104 | -4,590 | -707 | 933 | 13,241 |
| Pre-tax Income | -15,005 | -17,318 | -8,961 | -6,287 | -2,975 |
| Net Income Continuous | -15,005 | -17,318 | -8,961 | -6,287 | -2,975 |
| Net Income | $-15,005 | $-17,318 | $-8,961 | $-6,287 | $-2,975 |
| EPS Basic Total Ops | -1.62 | -2.74 | -2.84 | -2.08 | -1.04 |
| EPS Basic Continuous Ops | -1.62 | -2.74 | -2.86 | -2.08 | -1.03 |
| EPS Diluted Total Ops | -1.62 | -2.74 | -2.84 | -2.08 | -1.04 |
| EPS Diluted Continuous Ops | -1.62 | -2.74 | -2.86 | -2.08 | -1.03 |
| EPS Diluted Before Non-Recurring Items | -2.16 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-15,105 | $-12,062 | $-5,886 | $-7,134 | $-16,161 |